Abbott, Elan Drop Tricor IP Suits Against Biovail

Law360, New York (April 4, 2011, 4:35 PM EDT) -- Abbott Laboratories and Elan Corp. PLC continued Thursday to wrap up a campaign to block generic versions of the cholesterol drug Tricor, resolving lawsuits against Biovail Corp., which is now owned by Valeant Pharmaceuticals International Inc.

Judge Garrett E. Brown Jr. of the U.S. District Court for the District of New Jersey dismissed Abbott’s infringement suit against Biovail, and signed off on an identical stipulation resolving Elan’s suit over three other Tricor patents.

Abbott and Elan each agreed to dismiss their respective suits against Biovail, with...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.